Phase II trial of KPI 10 in patients with bacterial infections.

Trial Profile

Phase II trial of KPI 10 in patients with bacterial infections.

Planning
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2012

At a glance

  • Drugs KPI 10 (Primary)
  • Indications Bacterial infections
  • Focus Therapeutic Use
  • Sponsors Kalidex Pharmaceuticals
  • Most Recent Events

    • 11 Sep 2012 Planned initiation date changed from 1 Jun 2012 to 1 Jun 2013.
    • 11 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top